The Procter & Gamble Company Share-based Payment Arrangement, Expense, Tax Benefit
The Procter & Gamble Company (PG) reported Share-based Payment Arrangement, Expense, Tax Benefit of $92.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-04
- The Procter & Gamble Company share-based payment arrangement, expense, tax benefit for fiscal 2026 was $92.00M, a 8.24% increase from fiscal 2025.
- The Procter & Gamble Company share-based payment arrangement, expense, tax benefit for fiscal 2025 was $85.00M, a 17.48% decline from fiscal 2024.
- The Procter & Gamble Company share-based payment arrangement, expense, tax benefit for fiscal 2024 was $103.00M, a 0.00% change from fiscal 2023.
- The Procter & Gamble Company share-based payment arrangement, expense, tax benefit for fiscal 2023 was $103.00M, a 17.05% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2026-06-30 | $92.00M 10-K · filed 2026-08-04 |
| 2025-06-30 | $85.00M 10-K · filed 2026-08-04 |
| 2024-06-30 | $103.00M 10-K · filed 2026-08-04 |
| 2023-06-30 | $103.00M 10-K · filed 2025-08-04 |
| 2022-06-30 | $88.00M 10-K · filed 2024-08-05 |
| 2016-06-30 | $85.00M 10-K · filed 2016-08-09 |
| 2015-06-30 | $109.00M 10-K · filed 2016-08-09 |
| 2014-06-30 | $127.00M 10-K · filed 2016-08-09 |
| 2013-06-30 | $96.00M 8-K · filed 2015-10-26 |
| 2012-06-30 | $102.00M 10-K · filed 2014-08-08 |
| 2011-06-30 | $117.00M 8-K · filed 2013-10-28 |
| 2010-06-30 | $118.00M 10-K · filed 2012-08-08 |
| 2009-06-30 | $137.00M 8-K · filed 2012-02-10 |
| 2008-06-30 | $147.00M 10-K · filed 2010-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |